Jennifer Hope Richardson

This inventor holds 3 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Cytomx Therapeutics, Inc., Amgen Fremont Inc., Dendreon Corporation. Active years: 2009-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer Hope Richardson. Retrieved from https://idiyas.com/inventor/jennifer-hope-richardson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 (Patent Applications = 4)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 8.1

ph-index = 2

Forward Citations = 33(Granted Patents)

Company Filing History:

2 out of 94

Cytomx Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 2009-2023

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11802158 - Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same (2023-10-31),

2. 10669337 - Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same (2020-06-02),

3. 7572444 - Binding proteins specific for human matriptase (2009-08-11),

Title: Jennifer Hope Richardson: Inspiring Innovator Making a Difference

Introduction:

Jennifer Hope Richardson, a visionary inventor based in Fremont, CA, is a beacon of inspiration in the field of innovation. With a relentless drive to create inventions that contribute to a better world, she embodies the spirit of groundbreaking creativity.

Latest Patents:

Jennifer holds a remarkable total of 3 patents, with her latest inventions focusing on bispecific anti-CD3 antibodies. These cutting-edge antibodies are designed to specifically bind to CD3, opening up new possibilities in therapeutic, diagnostic, and prophylactic applications.

Career Highlights:

Throughout her illustrious career, Jennifer has made significant contributions to companies such as CytomX Therapeutics, Inc. and Amgen Fremont Inc. Her innovative mindset and expertise have been instrumental in advancing research and development in the biotechnology industry.

Collaborations:

Jennifer has had the privilege of collaborating with esteemed professionals in the field, including Bryan Allen Irving and Sherry Lynn La Porte. Together, they have worked on groundbreaking projects that push the boundaries of what is possible in the world of biopharmaceuticals.

Conclusion:

In conclusion, Jennifer Hope Richardson's dedication to innovation and her passion for creating inventions that make a tangible difference highlight her as a true trailblazer in the realm of inventing. Her work serves as a testament to the power of creativity and perseverance in shaping a more promising future for all.

Profile summary based on public USPTO records.